Notice: This company has been marked as potentially delisted and may not be actively trading. Concert Pharmaceuticals (CNCE) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Magnum Wrestling event in Ralston will benefit pediatric cancer organizationSeptember 27, 2024 | omaha.comStar-Studded Rock4EB! Concert Raises Over $1 Million for 'Butterfly' Skin Disease Epidermolysis BullosaSeptember 23, 2024 | nz.news.yahoo.comMan who sold fentanyl-laced pill liable for $5.8 million in death of young female customerSeptember 20, 2024 | msn.comJaney Godley cancels tour and stops work ‘for the foreseeable future’September 18, 2024 | msn.comJane's Addiction cancels tour in the wake of an onstage fightSeptember 16, 2024 | msn.comHair loss, nosebleeds, and a Taylor Swift concert: How I coped with chemoSeptember 15, 2024 | msn.comBreast cancer drug could help prolong survival for children with brain tumors, study findsSeptember 6, 2024 | msn.comWhat’s happening in Portland throughout Labor Day weekendAugust 30, 2024 | msn.comThe Best Bag to Bring to a Concert Is Actually a Running BeltApril 7, 2024 | nytimes.comTeresa Giudice and Her Lookalike Daughters Glam Up for Nicki Minaj Concert: ‘New Jersey Takes Gag City’April 1, 2024 | au.news.yahoo.comVideo: Pharma boss apologises after pill linked to five deaths and over 100 hospitalisationsMarch 30, 2024 | msn.comNFL pushed networks to air Taylor Swift concert film promos — for freeOctober 28, 2023 | nypost.comBeyoncé 'Renaissance' Movie Tickets and How To See Concert Film in TheatersOctober 2, 2023 | msn.comTaylor Swift 'overjoyed' to release Eras Tour concert movie: How to watchSeptember 15, 2023 | usatoday.comBruce Springsteen forced to postpone Philadelphia concerts with E Street Band due to illnessSeptember 12, 2023 | usatoday.comMiranda Lambert scolds fans for taking selfies during her concert: 'I don't like it'August 7, 2023 | usatoday.comThe worst people at concerts, from self-involved selfie takers to nonstop filmersAugust 6, 2023 | usatoday.comHighlights from King Charles III Coronation concertJuly 25, 2023 | bbc.co.ukFan throws bag of ashes at Pink during tour concertJuly 17, 2023 | usatoday.comBirds Papaya stuns fans in Shania Twain-inspired outfit for concertJuly 4, 2023 | ca.style.yahoo.comHow to watch the Coronation and Coronation Concert on BBC TV and iPlayer and listen on radio and BBC SoundsMay 7, 2023 | bbc.comTicket ballot for the Coronation ConcertMay 4, 2023 | bbc.co.ukConcert Pharmaceuticals (NASDAQ:CNCE) Earns Sell Rating from Analysts at StockNews.comStockNews.com began coverage on Concert Pharmaceuticals in a research note on Wednesday. They set a "sell" rating on the stock.April 5, 2023 | marketbeat.comConcert Pharmaceuticals (NASDAQ:CNCE) Coverage Initiated at StockNews.comStockNews.com assumed coverage on Concert Pharmaceuticals in a research note on Tuesday. They set a "sell" rating on the stock.March 28, 2023 | marketbeat.comWho is Florence Price? Find out at a free Philadelphia Orchestra concert SaturdayMarch 26, 2023 | msn.comAssenagon Asset Management S.A. Lowers Holdings in Concert Pharmaceuticals, Inc. (NASDAQ:CNCE)Assenagon Asset Management S.A. trimmed its position in shares of Concert Pharmaceuticals, Inc. (NASDAQ:CNCE - Get Rating) by 15.4% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 769,336 shares of the biotechnology company's stock after selling 140,554March 26, 2023 | marketbeat.comConcert Pharmaceuticals (NASDAQ:CNCE) Coverage Initiated by Analysts at StockNews.comStockNews.com started coverage on Concert Pharmaceuticals in a research note on Monday. They set a "sell" rating on the stock.March 20, 2023 | marketbeat.comRenaissance Technologies LLC Sells 285,579 Shares of Concert Pharmaceuticals, Inc. (NASDAQ:CNCE)Renaissance Technologies LLC cut its stake in shares of Concert Pharmaceuticals, Inc. (NASDAQ:CNCE - Get Rating) by 30.8% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 642,605 shares of the biotechnology company's stock after selling 285,5March 13, 2023 | marketbeat.comTrading was temporarily halted for "CNCE" at 07:03 PM with a stated reason of "News pending."March 6, 2023 | marketbeat.comCantor Fitzgerald L. P. Takes Position in Concert Pharmaceuticals, Inc. (NASDAQ:CNCE)Cantor Fitzgerald L. P. bought a new position in shares of Concert Pharmaceuticals, Inc. (NASDAQ:CNCE - Get Rating) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor bought 42,100 shares of the bioteMarch 3, 2023 | marketbeat.comConcert Pharmaceuticals (NASDAQ:CNCE) Cut to "Sell" at StockNews.comStockNews.com downgraded shares of Concert Pharmaceuticals from a "hold" rating to a "sell" rating in a report on Friday.February 25, 2023 | marketbeat.comConcert Pharmaceuticals Maintains Deuruxolitinib Breakthrough Therapy Designation from FDA for the Treatment of Alopecia AreataFebruary 15, 2023 | finance.yahoo.comHarvest Investment Services LLC Makes New $282,000 Investment in Concert Pharmaceuticals, Inc. (NASDAQ:CNCE)Harvest Investment Services LLC purchased a new stake in Concert Pharmaceuticals, Inc. (NASDAQ:CNCE - Get Rating) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 42,122 shares of the biotechnology compaFebruary 8, 2023 | marketbeat.comAnalysts Are Neutral on These Healthcare Stocks: Zimmer Biomet Holdings (ZBH), Concert Pharma (CNCE)February 6, 2023 | markets.businessinsider.comInternational Biotechnology Trust PLC Acquires 198,190 Shares of Concert Pharmaceuticals, Inc. (NASDAQ:CNCE)International Biotechnology Trust PLC lifted its holdings in shares of Concert Pharmaceuticals, Inc. (NASDAQ:CNCE - Get Rating) by 7,593.5% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 200,800 shares of the bioteFebruary 1, 2023 | marketbeat.comMoore Kuehn Encourages KERN, CNCE, AQUA and ANGN Investors to Contact Law FirmJanuary 30, 2023 | benzinga.comConcert (CNCE) Stock Up 17% Last Week on Sun Pharma Buyout OfferJanuary 23, 2023 | finance.yahoo.comConcert Pharmaceuticals, Inc. to Post FY2027 Earnings of $0.39 Per Share, Jefferies Financial Group Forecasts (NASDAQ:CNCE)Concert Pharmaceuticals, Inc. (NASDAQ:CNCE - Get Rating) - Investment analysts at Jefferies Financial Group issued their FY2027 earnings per share estimates for Concert Pharmaceuticals in a research report issued on Thursday, January 19th. Jefferies Financial Group analyst M. Raycroft expects thaJanuary 23, 2023 | marketbeat.com5 big deal reports: Sun Pharma’s $576M pact for Concert PharmaJanuary 22, 2023 | msn.comStockNews.com Downgrades Concert Pharmaceuticals (NASDAQ:CNCE) to SellStockNews.com lowered Concert Pharmaceuticals from a "hold" rating to a "sell" rating in a research report on Friday.January 21, 2023 | marketbeat.comWhy Concert Pharmaceuticals Stock Rocketed Higher This WeekJanuary 20, 2023 | finance.yahoo.comCNCE Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Concert Pharmaceuticals, Inc. Is Fair to ShareholdersJanuary 20, 2023 | marketwatch.comSHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Concert Pharmaceuticals, Inc. (CNCE)January 19, 2023 | benzinga.comShareholder Alert: Ademi LLP investigates whether Concert Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with Sun PharmaJanuary 19, 2023 | benzinga.comConcert Pharmaceuticals Shares Rally on Takeover by Sun >CNCEJanuary 19, 2023 | marketwatch.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Concert Pharmaceuticals, Inc. BuyoutJanuary 19, 2023 | wsj.comIndia-Based Sun Pharma Scoops Up Concert Pharmaceuticals For $576M Plus MilestonesJanuary 19, 2023 | finance.yahoo.comPharma giant in India buys Concert Pharmaceuticals in $576M dealJanuary 19, 2023 | finance.yahoo.comSun Pharmaceutical to Buy Concert Pharmaceuticals For Initial $576 Million >CNCEJanuary 19, 2023 | marketwatch.comSun Pharma to Acquire Concert Pharmaceuticals, Advancing the Potential Treatment of Alopecia AreataJanuary 19, 2023 | finance.yahoo.com Get Concert Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CNCE and its competitors with MarketBeat's FREE daily newsletter. Email Address No one’s talking about these Trump trades (Ad)As you likely know, the “Trump bump” launched stocks to record highs after he secured his second reelection bid. Now, Trump and his team are coming to gut government regulation – and it’s going to create some incredible market opportunities. But while the masses chase large-cap tech and so-called AI stocks, a small circle of traders are using a strange but tactical method to find a pool of “hidden Trump trades.” Go here to see how you can start accessing these opportunities today CNCE Media Mentions By Week CNCE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CNCE News Sentiment▼0.400.60▲Average Medical News Sentiment CNCE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CNCE Articles This Week▼00▲CNCE Articles Average Week Get Concert Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CNCE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SDGR News ARQT News NRIX News RCUS News KNSA News OCUL News MRVI News TVTX News AUPH News PRAX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CNCE) was last updated on 12/23/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Concert Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Concert Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
